申请人:Sova Pharmaceuticals, Inc.
                            
                            
                                公开号:US20170327478A1
                            
                            
                                公开(公告)日:2017-11-16
                            
                            Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit cystathionine-γ-lyase (CSE). Also described herein are methods for using such CSE inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from CSE inhibition.